News Sentiment

ATRC sentiment intelligence

AtriCure Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 34.28 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+7.8% over one week, +19.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Is AtriCure's (ATRC) Russell 2000 Defensive Debut Quietly Reframing Its Risk‑Reward Profile?

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 7.8% Price confirming higher
Trend fit Trend inactive 19.1% over four weeks
Fair value 3.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 32
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 7
TradingView 5
Stock Titan 5
TradingKey 5
Simply Wall Street 4
Moomoo 2
Investing.com 2
The Motley Fool 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 11
Balance sheet 3
Analyst action 3
Guidance 2
Deals and strategy 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 49
Simply Wall Street Direct company coverage

Is AtriCure's (ATRC) Russell 2000 Defensive Debut Quietly Reframing Its Risk‑Reward Profile?

AtriCure (ATRC) has been added to the Russell 2000 Defensive and Growth-Defensive Indexes, potentially broadening its investor base. This inclusion, along with recent executive share purchases, could influence investor perception, though upcoming Q2 2026 earnings are anticipated

Tone
Positive 60/100
Event
Earnings
Published
07 Jul 2026 09:40
Source
Simply Wall Street
Stock Traders Daily Direct company coverage

(ATRC) Movement Within Algorithmic Entry Frameworks

This article analyzes Atricure Inc. (NASDAQ: ATRC) using algorithmic entry frameworks. It highlights a strong near and mid-term sentiment but a weak long-term outlook, with an exceptional risk-reward setup. The analysis provides three distinct institutional trading strategies—Pos

Tone
Positive 65/100
Event
Guidance
Published
06 Jul 2026 11:11
Source
Stock Traders Daily
Simply Wall Street Direct company coverage

Is AtriCure (ATRC) Still Undervalued Following Its Russell Defensive Index Additions?

AtriCure (ATRC) has been added to the Russell 2000 Growth-Defensive and Defensive Indices after a recent share price rebound. While analysts peg its fair value at $47.00, suggesting undervaluation based on growth assumptions, a discounted cash flow model presents a more conservat

Tone
Neutral 50/100
Event
Balance sheet
Published
05 Jul 2026 23:11
Source
Simply Wall Street
TradingView Direct company coverage

Price to sales forward of AtriCure, Inc. – NASDAQ:ATRC

The article focuses on the "Price to sales forward" metric for AtriCure, Inc. (NASDAQ: ATRC). It appears to be a financial data snippet or a minor report from TradingView, providing a specific valuation metric for the company.

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 00:10
Source
TradingView
Stock Titan Direct company coverage

AtriCure (ATRC) CLO acquires 636 shares in ESPP purchase

AtriCure, Inc.'s Chief Legal Officer, Karl S. Dahlquist, acquired 636 shares of common stock through the company’s 2018 Employee Stock Purchase Plan on June 30, 2026. These shares were purchased at $23.78 each, representing 85% of the closing price on that date, increasing his di

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 12:09
Source
Stock Titan
Market source Direct company coverage

AtriCure to Announce Second Quarter 2026 Financial Results

AtriCure, Inc. (NASDAQ: ATRC) announced that it will release its second quarter 2026 financial results on Thursday, July 23, 2026. The company will also host an audio webcast at 4:30 p.m. Eastern Time on the same day to discuss these results. Interested parties can register onlin

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 11:39
Source
Market source
Stock Titan Direct company coverage

AtriCure (ATRC) COO adds ESPP shares in routine acquisition

AtriCure, Inc. Chief Operating Officer Douglas J. Seith acquired 527 shares of common stock through the company’s 2018 Employee Stock Purchase Plan. The shares were purchased at $23.78 each, reflecting an 85% discount of the closing price on June 30, 2026, and increased his direc

Tone
Neutral 50/100
Event
Deals and strategy
Published
03 Jul 2026 10:40
Source
Stock Titan
Stock Titan Direct company coverage

AtriCure (ATRC) CTO adds shares through discounted Employee Stock Purchase Plan

AtriCure's Chief Technical Officer, Salvatore Privitera, acquired 636 shares of company stock through the 2018 Employee Stock Purchase Plan (ESPP) on June 30, 2026. These shares were purchased at a discounted price of $23.78 each, representing 85% of the closing price of $27.98 o

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 10:10
Source
Stock Titan
Moomoo Direct company coverage

Press Release: AtriCure to Announce Second Quarter 2026 Financial Results

AtriCure, Inc. (Nasdaq: ATRC) announced it will release its second quarter 2026 financial results after the market closes on Tuesday, August 4, 2026. The company will also host a conference call and webcast to discuss the results and provide a business update on the same day at 4

Tone
Neutral 50/100
Event
Earnings
Published
02 Jul 2026 22:39
Source
Moomoo
Investing.com Canada Direct company coverage

Form 4 AtriCure Inc For: 2 July By Investing.com

This article announces the filing of Form 4 for AtriCure Inc. on July 2nd. It provides key stock market data for various indices, commodities, and individual stocks. The content also includes a list of popular news and analysis articles from Investing.com.

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 12:40
Source
Investing.com Canada
Stock Titan Direct company coverage

AtriCure (ATRC) CEO adds 636 shares through 2018 Employee Stock Purchase Plan

AtriCure, Inc.'s President and CEO, Michael H. Carrel, acquired 636 shares of common stock at $23.78 per share through the company's 2018 Employee Stock Purchase Plan. This transaction, executed on June 30, 2026, increased his direct holdings to 779,134 shares. The shares were pu

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 12:40
Source
Stock Titan
Stock Titan Direct company coverage

AtriCure, Inc. (ATRC) CSO acquires 636 ESPP shares at discount

AtriCure, Inc.'s Chief Scientific Officer, Doraiswamy Vinayak, acquired 636 shares of common stock through the company's 2018 Employee Stock Purchase Plan. The shares were purchased on June 30, 2026, at a discounted price of $23.78 per share, which is 85% of the closing price of

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 12:40
Source
Stock Titan
Investing.com Direct company coverage

Canaccord reiterates AtriCure stock Buy rating after FDA clearance

Canaccord Genuity has reiterated its Buy rating and a $55.00 price target for AtriCure Inc. (NASDAQ:ATRC) following FDA clearance for a competing left atrial appendage exclusion system from Edwards Lifesciences. Despite the new competition, Canaccord expects minimal impact on Atr

Tone
Neutral 50/100
Event
Analyst action
Published
30 Jun 2026 22:09
Source
Investing.com
Simply Wall Street Direct company coverage

AtriCure (ATRC) Joins Multiple Russell 2000 Defensive Indexes Is Its Risk Profile Evolving?

AtriCure (ATRC) has been added to the Russell 2000 Growth-Defensive and Defensive indexes, which could boost its visibility and liquidity. While this inclusion may attract investment, the fundamental risks and opportunities related to its product pipeline and competition, particu

Tone
Positive 64/100
Event
Balance sheet
Published
29 Jun 2026 20:14
Source
Simply Wall Street
Market source Direct company coverage

Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic

Edwards Lifesciences has received FDA clearance for its Ecliptis left atrial appendage exclusion system, positioning it to compete with AtriCure's AtriClip and Medtronic's Penditure system. The device aims to prevent stroke in atrial fibrillation patients by closing the LAA. Edwa

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 11:39
Source
Market source
TradingView Direct company coverage

AtriCure, Inc. Actuals & Estimates (NASDAQ:ATRC)

This article provides an overview of AtriCure, Inc. (NASDAQ: ATRC) stock, including its current price of $30.18, market capitalization of $1.42 billion, and recent performance. It details analyst forecasts, with a maximum estimate of $55.00 and a minimum of $36.00, and mentions k

Tone
Positive 64/100
Event
Analyst action
Published
26 Jun 2026 21:09
Source
TradingView
TradingView Direct company coverage

ATRC Forecast — Price Target — Prediction for 2027

The article provides an overview of AtriCure, Inc. (ATRC) stock, including its current price, analyst forecasts, and historical performance. It details financial metrics such as revenue, net income, and market capitalization, along with upcoming earnings dates. The content also a

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 09:40
Source
TradingView
TradingView Direct company coverage

AtriCure, Inc. Actuals & Estimates (DUS:A5I)

This article provides financial actuals and estimates for AtriCure, Inc. (DUS:A5I), including its stock ticker, analyst forecast, historical prices, revenue, net income, and EBITDA. It also notes that the company does not pay dividends and details its next earnings report date.

Tone
Positive 63/100
Event
Earnings
Published
26 Jun 2026 03:40
Source
TradingView
TradingKey Direct company coverage

AtriCure Inc (ATRC) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for AtriCure Inc (ATRC), detailing its volatility, financial risk, and investment risk. The company has a risk assessment score of 6.67, ranking 52 out of 204 in the Healthcare Equipment & Supplies industry, and a beta of 1.27, indicating h

Tone
Negative 40/100
Event
Market update
Published
24 Jun 2026 02:41
Source
TradingKey
Simply Wall Street Direct company coverage

AtriCure (ATRC) Stock Could Be 45.4% Undervalued As Growth Narrative Faces A Cash Flow Test

AtriCure (ATRC) stock is currently trading around $28.80, with one narrative suggesting it is 45.4% undervalued with a fair value of $52.78, based on strong growth assumptions from its innovative medical devices. However, a discounted cash flow (DCF) model presents a contrasting

Tone
Negative 28/100
Event
Balance sheet
Published
21 Jun 2026 18:09
Source
Simply Wall Street
Market source Direct company coverage

AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock?

AtriCure (ATRC) shares rose 6.2% after a presentation at the Goldman Sachs Global Healthcare Conference, where management reiterated a goal of $1 billion in revenue by 2030 and highlighted market expansion potential from clinical trials. Despite the surge, the stock holds a Zacks

Tone
Positive 65/100
Event
Earnings
Published
19 Jun 2026 11:40
Source
Market source
TradingKey Direct company coverage

AtriCure Inc (ATRC) Financial Health: Profitability & Balance Sheet Analysis

AtriCure Inc (ATRC) currently holds a robust financial score of 7.37, ranking 81st in the Healthcare Equipment & Supplies industry. The company reported a significant quarterly revenue increase of 14.26% year-over-year, reaching $141.25 million, and a net profit increase of 101.6

Tone
Positive 75/100
Event
Earnings
Published
18 Jun 2026 16:10
Source
TradingKey
TradingKey Direct company coverage

AtriCure Inc (ATRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of AtriCure Inc (ATRC), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that ATRC is trading between a resistance level of $30.29 and a support level of $26.34, suggesting poten

Tone
Positive 62/100
Event
Market update
Published
18 Jun 2026 07:44
Source
TradingKey
TradingKey Direct company coverage

AtriCure Inc (ATRC) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for AtriCure Inc (ATRC), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 10 analysts, the stock has a "Buy" trend with an average target price of $50.00 and an expected revenue of $152.0

Tone
Positive 81/100
Event
Earnings
Published
18 Jun 2026 06:38
Source
TradingKey
TradingKey Direct company coverage

AtriCure Inc (ATRC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure and institutional holdings of AtriCure Inc (ATRC). It lists the major shareholders, their proportion of holdings, and categorizes shareholders by type. The report also provides a historical overview of institutional shareholding data

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 21:10
Source
TradingKey